Literature DB >> 8726926

Increased content of hydrogen peroxide in the expired breath of cigarette smokers.

D Nowak1, A Antczak, M Krol, T Pietras, B Shariati, P Bialasiewicz, K Jeczkowski, P Kula.   

Abstract

Cigarette smoking causes an influx of mononuclear phagocytes and polymorphonuclear leucocytes into the lower airways. These cells have altered oxygen metabolism and release more H2O2 than phagocytes from nonsmokers. In this study, we intended to determine whether asymptomatic cigarette smokers exhale more H2O2 than healthy nonsmokers. The content of H2O2 in the expired condensate of 27 nonsmokers and 33 cigarette smokers was measured spectrofluorimetrically (homovanillic acid method). The mean H2O2 level in the expired breath condensate of all cigarette smokers was about fivefold higher than that found in the whole nonsmoker group (0.24 +/- 0.32 versus 0.05 +/- 0.11 nM). However, only 16 smokers (49%) and 6 nonsmokers (22%) had detectable levels of H2O2 in expired breath that reached values 0.49 +/- 0.28 and 0.23 +/- 0.10 nM, respectively. Although the cigarette smoking status was similar for both male and female smokers, females expired 2.5 fold less H2O2 than males (0.15 +/- 0.24 (n = 21) versus 0.38 +/- 0.39 (n = 12) nM. No correlation was found between expired H2O2 levels and cigarette smoking status expressed as the daily cigarette consumption, cumulative cigarette consumption and urinary cotinine concentration. It is suggested that in some smokers, expressed H2O2 can be a noninvasive marker of oxidant overload in the lower airways related to cigarette smoking.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8726926     DOI: 10.1183/09031936.96.09040652

Source DB:  PubMed          Journal:  Eur Respir J        ISSN: 0903-1936            Impact factor:   16.671


  27 in total

1.  Oxidative stress destabilizes protein arginine methyltransferase 4 via glycogen synthase kinase 3β to impede lung epithelial cell migration.

Authors:  Xiuying Li; Yandong Lai; Jin Li; Mingyi Zou; Chunbin Zou
Journal:  Am J Physiol Cell Physiol       Date:  2017-06-21       Impact factor: 4.249

Review 2.  Proteinases and oxidants as targets in the treatment of chronic obstructive pulmonary disease.

Authors:  Caroline A Owen
Journal:  Proc Am Thorac Soc       Date:  2005

3.  Examining the exhaled levels of hydrogen peroxide in rheumatoid arthritis: a pilot study.

Authors:  T R Mikuls; J R O'Dell; R Ertl; D A Bergman; S I Rennard
Journal:  Ann Rheum Dis       Date:  2006-09       Impact factor: 19.103

Review 4.  NADPH oxidase-derived ROS and the regulation of pulmonary vessel tone.

Authors:  G Frazziano; H C Champion; P J Pagano
Journal:  Am J Physiol Heart Circ Physiol       Date:  2012-03-16       Impact factor: 4.733

Review 5.  Lung injury and cancer: Mechanistic insights into ceramide and EGFR signaling under cigarette smoke.

Authors:  Tzipora Goldkorn; Simone Filosto
Journal:  Am J Respir Cell Mol Biol       Date:  2010-06-04       Impact factor: 6.914

Review 6.  Mechanisms and consequences of oxidative stress in lung disease: therapeutic implications for an aging populace.

Authors:  Louise Hecker
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2017-12-14       Impact factor: 5.464

7.  Is there any relationship between plasma antioxidant capacity and lung function in smokers and in patients with chronic obstructive pulmonary disease?

Authors:  I Rahman; E Swarska; M Henry; J Stolk; W MacNee
Journal:  Thorax       Date:  2000-03       Impact factor: 9.139

Review 8.  Structural and functional changes of peripheral muscles in chronic obstructive pulmonary disease patients.

Authors:  Roberto A Rabinovich; Jordi Vilaró
Journal:  Curr Opin Pulm Med       Date:  2010-03       Impact factor: 3.155

Review 9.  Mechanisms and function of DUOX in epithelia of the lung.

Authors:  Horst Fischer
Journal:  Antioxid Redox Signal       Date:  2009-10       Impact factor: 8.401

Review 10.  Lung cancer and lung injury: the dual role of ceramide.

Authors:  Tzipora Goldkorn; Samuel Chung; Simone Filosto
Journal:  Handb Exp Pharmacol       Date:  2013
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.